Observational studyBMC cancer2022

Proton pump inhibitors may reduce the efficacy of ribociclib and palbociclib in metastatic breast cancer patients based on an observational study.

Kadir Eser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.